Polymerase Theta Mediated End Joining: Mechanism and Essential Functions in Repair of Chromosome Breaks
聚合酶 Theta 介导的末端连接:染色体断裂修复的机制和基本功能
基本信息
- 批准号:9926844
- 负责人:
- 金额:$ 46.56万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-06-15 至 2022-05-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAnimal ModelBRCA1 geneBRCA2 geneBiological AssayBreast Cancer ModelCRISPR libraryCell SurvivalCellsChromosomal BreaksChromosomesClinicalClustered Regularly Interspaced Short Palindromic RepeatsCruciform DNADNA DamageDNA-Directed DNA PolymeraseDataDefectDevelopmentEffectivenessEmbryoEngineeringEquilibriumExcisionFibroblastsGenesGeneticGenetic EpistasisGenomeGenomic InstabilityHereditary Breast and Ovarian Cancer SyndromeHolliday Junction ResolvasesInterruptionInvertebratesInvestigationIonizing radiationKineticsLentivirus VectorLoss of HeterozygosityMalignant NeoplasmsMediatingMitoticModelingMolecularMusMutationNamesNonhomologous DNA End JoiningNormal CellPathway interactionsPolymerasePublishingResistanceResolutionRoleSister Chromatid ExchangeSiteStructureTherapeuticWorkcancer therapycell growthcontextual factorsexperimental studyflygenetic analysishomologous recombinationinhibitor/antagonistinsightloss of functionmutantnext generation sequencingnovelp53-binding protein 1repairedresponsetargeted cancer therapytherapeutic targettool
项目摘要
Project Summary/Abstract
Repair of chromosome breaks is essential for normal cell growth, protects against and promotes cancer-
causing genome rearrangements, and determines the effectiveness of many cancer therapies. In recent work
our group implicated DNA polymerase theta in a pathway for repairing chromosome breaks that favors short
sequence repeats (microhomologies). In Aim 1 we will outline the steps in Theta mediated end joining (TMEJ)
– its molecular mechanism - and determine the requirements for each step. We will employ a combination of
defined extrachromosomal substrates, analysis of repair of a targeted chromosomal break, and quantitative
assessments of effects on cell growth and viability when cells are defective in various steps. In aim 2 we will
clarify the relationship between Theta mediated end joining and another pathway for repair of chromosome
breaks, homologous recombination. Specifically, we will investigate how defects in BRCA1 and 53BP1, genes
involved in early steps common to both TMEJ and homologous recombination, impact the choice between
repair by these two pathways. We will then also address the importance of the TMEJ pathway as an alternative
to Holliday junction resolution, a late step specific to the homologous recombination pathway. We will exploit
assays for chromosomal end structure and repair, as well as genetic tools available through use of the
invertebrate model D. melanogaster. In aim 3 we will systematically look for novel genetic interactions with
Polymerase theta that are important for both general cell viability and cellular resistance to ionizing radiation.
We will employ a lentiviral vector based CRISPR library that was curated to focus on a subset of 310 genes
relevant to the DNA damage response. The proposed experiments will speak to how an important but as-yet
poorly understood pathway works, and especially when and why it represents the best solution to various
problems encountered in the course of repair of chromosome breaks.
项目摘要/摘要
染色体断裂的修复对于正常细胞生长至关重要,预防并促进癌症 -
引起基因组重排,并确定许多癌症疗法的有效性。在最近的工作中
我们的小组在修复染色体断裂的途径中实现了DNA聚合酶theta,有利于短暂的
序列重复序列(微观理学)。在AIM 1中,我们将概述Theta介导的结束连接的步骤(TMEJ)
- 其分子机制 - 并确定每个步骤的要求。我们将采用组合
定义的外染色体底物,靶向染色体断裂的修复分析和定量
评估对细胞在各个步骤中有缺陷时对细胞生长和生存能力的影响的评估。在目标2中,我们将
澄清theta介导的结束与修复染色体的另一种途径之间的关系
休息,同源重组。具体而言,我们将研究BRCA1和53BP1中的缺陷如何,基因
参与TMEJ和同源重组的早期步骤,影响
通过这两个途径维修。然后,我们还将解决TMEJ途径的重要性
霍利迪交界处分辨率,这是同源重组途径的较晚步骤。我们将利用
染色体末端结构和修复的测定法,以及通过使用的遗传工具
无脊椎动物模型D. melanogaster。在AIM 3中,我们将系统地寻找与
聚合酶theta对于一般细胞活力和对电离辐射的耐药性很重要。
我们将采用基于慢病毒矢量的CRISPR库,该库策划了专注于310个基因的子集
与DNA损伤反应有关。拟议的实验将谈到一个重要但尚未的重要性
了解途径不良,尤其是何时以及为什么代表各种方法的最佳解决方案
在修复染色体断裂过程中遇到的问题。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DALE A RAMSDEN其他文献
DALE A RAMSDEN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DALE A RAMSDEN', 18)}}的其他基金
Essential roles for Pol delta in Pol theta mediated end joining
Pol delta 在 Pol theta 介导的末端连接中的重要作用
- 批准号:
10595374 - 财政年份:2022
- 资助金额:
$ 46.56万 - 项目类别:
Polymerase theta, genome instability, and cancer
聚合酶θ、基因组不稳定性和癌症
- 批准号:
10202518 - 财政年份:2020
- 资助金额:
$ 46.56万 - 项目类别:
Polymerase theta, genome instability, and cancer
聚合酶θ、基因组不稳定性和癌症
- 批准号:
10468628 - 财政年份:2020
- 资助金额:
$ 46.56万 - 项目类别:
Polymerase theta, genome instability, and cancer
聚合酶θ、基因组不稳定性和癌症
- 批准号:
10640884 - 财政年份:2020
- 资助金额:
$ 46.56万 - 项目类别:
Cellular requirements for Pol theta function
Pol theta 功能的细胞要求
- 批准号:
10202520 - 财政年份:2020
- 资助金额:
$ 46.56万 - 项目类别:
Cellular requirements for Pol theta function
Pol theta 功能的细胞要求
- 批准号:
10640885 - 财政年份:2020
- 资助金额:
$ 46.56万 - 项目类别:
Cellular requirements for Pol theta function
Pol theta 功能的细胞要求
- 批准号:
10468629 - 财政年份:2020
- 资助金额:
$ 46.56万 - 项目类别:
相似国自然基金
髋关节撞击综合征过度运动及机械刺激动物模型建立与相关致病机制研究
- 批准号:82372496
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
利用碱基编辑器治疗肥厚型心肌病的动物模型研究
- 批准号:82300396
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
利用小型猪模型评价动脉粥样硬化易感基因的作用
- 批准号:32370568
- 批准年份:2023
- 资助金额:50.00 万元
- 项目类别:面上项目
丁苯酞通过调节细胞异常自噬和凋亡来延缓脊髓性肌萎缩症动物模型脊髓运动神经元的丢失
- 批准号:82360332
- 批准年份:2023
- 资助金额:31.00 万元
- 项目类别:地区科学基金项目
APOBEC3A驱动膀胱癌发生发展的动物模型及其机制研究
- 批准号:82303057
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
相似海外基金
DNA Damage and Immunogenicity in Ewing Sarcoma
尤文肉瘤中的 DNA 损伤和免疫原性
- 批准号:
10213196 - 财政年份:2021
- 资助金额:
$ 46.56万 - 项目类别:
Transcriptomic mechanisms underlying the immune modulating function and therapeutic efficacy of PARP inhibitors
PARP抑制剂免疫调节功能和治疗功效的转录组机制
- 批准号:
10095875 - 财政年份:2021
- 资助金额:
$ 46.56万 - 项目类别:
Project 2: Targeting DNA replication in BRCA-associated breast cancer
项目 2:针对 BRCA 相关乳腺癌中的 DNA 复制
- 批准号:
10396609 - 财政年份:2021
- 资助金额:
$ 46.56万 - 项目类别:
DNA Damage and Immunogenicity in Ewing Sarcoma
尤文肉瘤中的 DNA 损伤和免疫原性
- 批准号:
10360543 - 财政年份:2021
- 资助金额:
$ 46.56万 - 项目类别:
Transcriptomic mechanisms underlying the immune modulating function and therapeutic efficacy of PARP inhibitors
PARP抑制剂免疫调节功能和治疗功效的转录组机制
- 批准号:
10669071 - 财政年份:2021
- 资助金额:
$ 46.56万 - 项目类别: